期刊文献+

舒血宁对慢性阻塞性肺病急性加重期患者氧化/抗氧化失衡的影响 被引量:12

Effect of Shu Xue Ning on redressing oxidant / antioxidant imbalance in patients with chronic obstructive pulmonary disease during acute exacerbation periods
暂未订购
导出
摘要 目的探讨舒血宁对慢性阻塞性肺疾病急性加重期(AECOPD)患者氧化/氧化失衡的影响。方法将AECOPD患者随机分为常规治疗组及加用舒血宁治疗组,分别检测治疗前后各氧化指标的含量,并设健康对照组作比较。结果治疗前与健康对照组相比,AECOPD患者SOD、GSH及VE含量降低,MDA含量升高;治疗后,加用舒血宁注射液治疗组比常规治疗组以上各指标改善更明显。结论AECOPD患者存在严重的氧化/抗氧化失衡,舒血宁注射液有助于纠正其氧化/抗氧化失衡。 [Objective] To investigate the effect of Shu Xue Ning injection on redressing oxidant/antioxidant imbalance in the patients with chronic obstructive pulmonary disease during exacerbation periods (AECOPD). [Methods] 60 patients with AECOPD were randomly divided into two groups. One was treated with conventional therapies, the other was treated with Shu Xue Ning injection in addition to routine therapies, and healthy control was set up, The concentrations of SOD, MDA, GSH and Vitamin E were determined respectively before and after the treatment, [Result] Before the treatment, the contents of SOD, GSH, Vile in COPD group were lower and those of MDA were higher than the control. After the treatment, the contents of all indexes in Shu Xue Ning group changed more remarkably than the concentrations of conventional therapy group. [ Conclusion] There is a serious imbalance between oxidants and antioxidants in patients with AECOPD and Shu Xue Ning injection could redress this oxidant/antioxidant imbalance.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2007年第12期1499-1501,共3页 China Journal of Modern Medicine
关键词 慢性阻塞性肺疾病 氧化/抗氧化失衡 舒血宁 chronic obstructive pulmonary disease oxidanl/antioxidant imbalance Shu Xue Ning
  • 相关文献

参考文献10

  • 1MACNEE W.Oxidants/antioxidants and COPD[J].Chest,2000,117(5 Suppl):303-317.
  • 2慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5092
  • 3MACNEE W.Oxidants/antioxidants and chronic obstructive pulmonary disease:pathogenesis to therapy[J].Novartis Found Symp,2001,234:169-185.
  • 4FARKHUTDINOV UR,ABDRAKHMANOVA LM,FARKHUTDINOV RR.Effects of halotherapy on free radical oxidation in padents with chronic bronchitis[J].Klin Med (Mosk),2000,78(12):37-40.
  • 5RAHMAN I,SKWARSKA E,MACNEE W.Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease[J].Thorax,1997,52(6):565-568.
  • 6KAFOURY RM,PRYOR WA,SQUADRTTO GL,et al.Lipid ozonation products activate phospholipases A2,C,and D[J].Toxicol Appl Pharmacol,1998,150(2):338-349.
  • 7PAUWELS RA,BUIST AS,CALVERLY PM,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease.NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) Workshop summary[J].Am J Respir Crit Care Med,2001,163(5):1256-1276.
  • 8欧阳若芸,陈平,彭红.吸入糖皮质激素对慢性阻塞性肺疾病的抗炎效应(英文)[J].中国现代医学杂志,2004,14(19):26-29. 被引量:4
  • 9潘洪平.银杏叶制剂药理作用和临床应用研究进展[J].中国中药杂志,2005,30(2):93-96. 被引量:92
  • 10黄斌.舒血宁对肺心病急性发作期患者心肺功能的影响[J].广西医科大学学报,2000,17(4):657-658. 被引量:1

二级参考文献32

共引文献5184

同被引文献117

引证文献12

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部